Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Mander

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Plos One|March 9, 2011
Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studiesDesiree C Wilks, Stephen J Sharp, Ulf Ekelund, et al.
Diabetes Care|October 11, 2022
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201Randy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
Diabetes Care|September 23, 2022
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 DiabetesRandy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
Obesity (Silver Spring, Md.)|February 19, 2013
Genetic predisposition to an adverse lipid profile limits the improvement in total cholesterol in response to weight lossCelia G Walker, Christina Holzapfel, Ruth J F Loos, et al.
British Journal of Cancer|August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatmentsJames M S Wason, Jean E Abraham, Richard D Baird, et al.
Trials|May 18, 2022
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetesDavid B Dunger, Sylvaine F A Bruggraber, Adrian P Mander, et al.
British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.
The American Journal of Clinical Nutrition|August 31, 2012
Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fishLucy M Browning, Celia G Walker, Adrian P Mander, et al.
The American Journal of Clinical Nutrition|April 7, 2007
Use of stable-isotope techniques to validate infant feeding practices reported by Bangladeshi women receiving breastfeeding counselingSophie E Moore, Andrew M Prentice, W Andy Coward, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2018
Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at HomeRuben H Willemsen, Keith Burling, Peter Barker, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Plos One|March 9, 2011
Objectively measured physical activity and fat mass in children: a bias-adjusted meta-analysis of prospective studiesDesiree C Wilks, Stephen J Sharp, Ulf Ekelund, et al.
Diabetes Care|October 11, 2022
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201Randy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
Diabetes Care|September 23, 2022
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 DiabetesRandy L Anderson, Linda A DiMeglio, Adrian P Mander, et al.
Obesity (Silver Spring, Md.)|February 19, 2013
Genetic predisposition to an adverse lipid profile limits the improvement in total cholesterol in response to weight lossCelia G Walker, Christina Holzapfel, Ruth J F Loos, et al.
British Journal of Cancer|August 12, 2015
A Bayesian adaptive design for biomarker trials with linked treatmentsJames M S Wason, Jean E Abraham, Richard D Baird, et al.
Trials|May 18, 2022
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetesDavid B Dunger, Sylvaine F A Bruggraber, Adrian P Mander, et al.
British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.
The American Journal of Clinical Nutrition|August 31, 2012
Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fishLucy M Browning, Celia G Walker, Adrian P Mander, et al.
The American Journal of Clinical Nutrition|April 7, 2007
Use of stable-isotope techniques to validate infant feeding practices reported by Bangladeshi women receiving breastfeeding counselingSophie E Moore, Andrew M Prentice, W Andy Coward, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2018
Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at HomeRuben H Willemsen, Keith Burling, Peter Barker, et al.
Pageof 8